AAMRI welcomes the opportunity to provide feedback on the Tax Discussion Paper. This submission relates to Chapter 7 on the not-for-profit (NFP) sector, and specifically focuses on the effect of...

The National Survey of Research Commercialisation (NSRC) provides a potentially valuable snapshot of commercialisation activities taking place in Australian publicly-funded research...

AAMRI endorses the review panel’s focus on the four key areas of sustainability, efficiency, collaboration and research translation as key determinants of the strength and success of independent...

As the peak body for Australian medical research institutes, AAMRI represents ~40 registered Health Promotion Charities (HPCs). In its feedback on the exposure draft of the Commissioner’s...

The draft 2015 Higher Education Research Data Collection (HERDC) Specifications include important changes that will mean universities will no longer be able to include the research income of...

The Medical Research Future Fund (MRFF), together with concurrent Government reviews impacting the health and medical research sector – including the Review to Strengthen Independent Medical...

The Significant Investor Visa (SIV) is a visa category for people who are willing to invest at least A$5 million into complying investments in Australia and want to maintain business and...

By all available measures of impact and success, Australia’s independent medical research institutes (iMRIs) are the jewel in the crown of Australia’s health and medical research sector. Through...

In its response to the Boosting the Commercial Returns from Research discussion paper, AAMRI contends that the most important barrier to the commercial translation of research is limited access...